Physician profile
Mauricio E Pons
NPI 1376723759
$2,883.69
in general payments reported to CMS, 2019-2025
18 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $112 · 2021: $598 · 2022: $233 · 2023: $359 · 2024: $631 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $996.57 | 2019-2025 | Rocklatan, Argos, Clareon |
| Abbvie INC. | $616.77 | 2022-2025 | |
| Allergan, INC. | $272.77 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $192.04 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $162.59 | 2021-2025 | Acthar |
| Astellas Pharma US INC | $101.19 | 2025 | Izervay |
| Horizon Therapeutics Plc | $92.31 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $89.56 | 2022-2025 | Syfovre |
| Genentech USA, INC. | $75.42 | 2025 | Vabysmo |
| Carl Zeiss Meditec, INC. | $57.26 | 2021 | |
| Ani Pharmaceuticals, INC. | $51.96 | 2024-2025 | Purified Cortrophin Gel |
| Harrow Eye, LLC | $45.40 | 2024-2025 | Vevye |
| Dompe US, INC. | $38.75 | 2021 | |
| Eyepoint US, INC. | $20.30 | 2021 | |
| Iridex Corporation | $18.75 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $17.76 | 2022 | |
| Bausch & Lomb Americas INC. | $17.65 | 2024 | Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $16.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mauricio Pons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.